Retrospective analysis reveals high antimicrobial resistance in complicated urinary tract infections, suggesting urgent need for targeted interventions.
• High resistance to ciprofloxacin and ceftriaxone in uropathogens • Emerging carbapenem resistance in Pseudomonas aeruginosa and Klebsiella pneumoniae • Prior antibiotic use predicts for carbapenem resistance • Nitrofurantoin and fosfomycin remain effective for common uripathogens • Multidrug resistance associated with prolonged hospital stay Antimicrobial resistance (AMR) is a major challenge in complicated urinary tract infections (cUTIs), particularly among high-risk patients in resource-limited settings. This retrospective study (January 2019– December 2023) analyzes 622 urine culture–positive samples from cUTI patients at a rehabilitation center to investigate pathogen distribution, AMR patterns, and associations with clinical outcomes using descriptive statistics and regression models. Escherichia coli (46%) was the predominant isolate, followed by Klebsiella pneumoniae (16%). Although Enterococcus faecalis and Pseudomonas aeruginosa were less common, their prevalence increased over time. High resistance rates to ciprofloxacin and ceftriaxone were observed in E. coli (69.5%, 74.7%) and K. pneumoniae (60.2%, 58.1%). Carbapenem resistance emerged in P. aeruginosa (51.4%) and K. pneumoniae (37.5%), with prior antibiotic exposure identified as a significant predictor (OR: 2.15; 95% CI:1.33-3.47; p = 0.002). In contrast, E. coli and E. faecalis retained high susceptibility to nitrofurantoin and fosfomycin. Multidrug-resistant (MDR) infections were independently associated with prolonged hospital stay (β = 1.889; p = 0.045). The high prevalence of resistance to first-line agents and emergence of carbapenem resistance underscore the urgent need for antimicrobial stewardship (AMS) interventions. The study suggests specific hospital-setting AMS should be prioritized the judicious use of agents such as nitrofurantoin and fosfomycin, which retain clinical effectiveness. Addressing MDR is crucial as it represents a key modifiable determinant of length of hospital stay in patients with cUTI.
No takes yet. Share an insight, caveat, or question.
Do et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: